Pharmacy in preparation for Gene Therapy
Gene therapy for haemophilia is classified as a genetically modified organism (GMO) product, meaning hospital pharmacies require official authorization to use it. Pharmacies in gene therapy dosing centers must meet specialized technical standards and have pharmacists trained in gene therapy protocols.
Join us for our latest Gene Therapy in Hemophilia webinar to dive deeper into the essential roles of pharmacists and nurses in this transformative treatment. You’ll learn about the pharmacist’s role in preparing the gene construct for patient dosing, and the nurse’s approach to safely handling and administering gene therapy, from transportation to administration and immediate reaction management
Register now to stay at the forefront of haemophilia treatment!
Agenda:
- Introduction, Ana Boban
- Gene Therapy preparation from pharmacists’ perspective, Claudia Neuhaus and Katrin Ingram Sieber
- Handling the drug outside the pharmacy from nurse’s perspective, Sara Garcia Barcenilla
- Q&A
- Wrap up, Ana Boban